← Back to Venture Matrix
US SEC Form D Record

Accipiter Biosciences Inc.

ROIPAD RESEARCH · PUBLIC SOURCES

Entity and market context

Snapshot 2026-11-07 03:30:13 UTC · Sources and methodology

CALCULATED FROM STORED SOURCE RECORDS

What this SEC filing reports

Offering amount: $10,492,778. Amount recorded as sold: $10,492,778.

Filing date 2026-07-28. These are filing fields, not an independently verified funding announcement. Zero values may represent missing or zero-reported data.

Open source record
View External Record
SEC Filing Date
Jul 28, 2026
Capital / Financials
$10.5M Offered (SEC filing)
Funding stage not verified
Registered Location
SEATTLE,
Legal Status
9 Backers
Industry Classification
Biotechnology
Corporate Dossier
Listed Founders / Executives
  • Matthew Bick
  • Hector De Jesus Rincon Arano
  • Javier Castellanos
  • Heather Redman
  • Randall Schatzman
  • William Canestaro
  • Jose Antonio Mesa Cejudo
Semantic Peers & Competitors ROOT: BIOTECHNOLOGY

These records share industry text with this entity. Text overlap is exploratory and does not establish that the entities are competitors or commercially comparable.

US SEC filing
Entera Bio Ltd. (ENTX)
$275M Offered (SEC filing)
US SEC filing
Georgiamune, Inc.
$131.9M Offered (SEC filing)